Dozens of medications address cardiovascular disease, but what do physicians want from future antiplatelet therapies? National survey of 300 cardiologists gives theheart.org readers an exclusive look
Continuing medical education (CME) serves to improve the quality of medical care. Expert faculty Drs. Harrington, Blumenthal, Gibson and Young discuss the role of CME in contemporary medicine, the evolution and impact of e-CME in the medical community and the future of CME and its financial support.
Thrombosis-associated major adverse cardiac events (MACE) occur in acute coronary syndromes (ACS) despite treatment with existing antiplatelet regimens. This review will examine the literature to define the extent and potential reasons for excess thrombotic events in both invasively and medically managed populations. Including video interviews with Drs. Becker, Cannon, and Wallentin.
The Sudden Cardiac Arrest Association is the nation's largest public advocacy organization singularly dedicated to sudden cardiac arrest (SCA) awareness and prevention. Its network of chapters, affiliates and volunteers include SCA survivors, patients at risk, physicians, nurses, EMTs and others touched by SCA. SCAA and its members work to expand public knowledge of SCA, improve emergency response to SCA victims, and encourage access to preventative medical care to patients at risk.
Prevention of cardiovascular disease is an important public health goal. Join Drs Leiter, Ridker, and Kastelein as they discuss the results of the JUPITER study which tested the hypothesis that 20 mg of rosuvastatin daily would reduce the rate of first major cardiovascular events in subjects with low LDL-C but high hsCRP
The RecordAF registry is a unique worldwide initiative dedicated to the improvement of the management of atrial fibrillation (AF) in day-to-day clinical practice. Join Dr Peter Kowey's presentation to learn about the design, rationale, objectives and expected outcomes of the first large-scale international prospective registry on atrial fibrillation.
Diabetes morbidity and mortality are attributed to vascular complications, both macrovascular (myocardial infarction and stroke) and microvascular (retinopathy and nephropathy). Epidemiologic data confirms a strong positive correlation between systolic blood pressure and the risk of these complications. Join our faculty as they present the results of the ADVANCE trial, the largest trial to date of patients with type 2 diabetes, which was designed to determine if tighter control of blood pressure lowering and close management of glucose levels would reduce the risk of all complications in adults with type 2 diabetes. Featuring Drs Fox, Chalmers, MacMahon, Marre, and Poulter.
Join chair Dr Mohammed Balghith and experts for a case-based presentation on learning to apply the right technique and equipment for specific coronary intervention cases, and to rapidly identify complications during the intervention and act accordingly. Experts include Drs Waqar Habib, Mohamed Arafa, Mohammed Kurdi, Abdullateef Y Khoja, and Layth A Mimish.